229 related articles for article (PubMed ID: 19013003)
1. Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.
Savage WJ; Barber JP; Mukhina GL; Hu R; Chen G; Matsui W; Thoburn C; Hess AD; Cheng L; Jones RJ; Brodsky RA
Exp Hematol; 2009 Jan; 37(1):42-51. PubMed ID: 19013003
[TBL] [Abstract][Full Text] [Related]
2. The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria.
Ware RE; Nishimura J; Moody MA; Smith C; Rosse WF; Howard TA
Blood; 1998 Oct; 92(7):2541-50. PubMed ID: 9746796
[TBL] [Abstract][Full Text] [Related]
3. Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis/immune response in 'normal' phenotype cells.
Chen G; Zeng W; Maciejewski JP; Kcyvanfar K; Billings EM; Young NS
Leukemia; 2005 May; 19(5):862-8. PubMed ID: 15759038
[TBL] [Abstract][Full Text] [Related]
4. Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype.
Nishimura Ji ; Phillips KL; Ware RE; Hall S; Wilson L; Gentry TL; Howard TA; Murakami Y; Shibano M; Machii T; Gilboa E; Kanakura Y; Takeda J; Kinoshita T; Rosse WF; Smith CA
Blood; 2001 May; 97(10):3004-10. PubMed ID: 11342424
[TBL] [Abstract][Full Text] [Related]
5. Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria.
Brodsky RA; Vala MS; Barber JP; Medof ME; Jones RJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8756-60. PubMed ID: 9238050
[TBL] [Abstract][Full Text] [Related]
6. Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor-deficient PIG-A mutant cells.
Szpurka H; Schade AE; Jankowska AM; Maciejewski JP
Br J Haematol; 2008 Jul; 142(3):413-22. PubMed ID: 18544084
[TBL] [Abstract][Full Text] [Related]
7. Superior growth of glycophosphatidy linositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo.
Chen G; Kirby M; Zeng W; Young NS; Maciejewski JP
Exp Hematol; 2002 Jul; 30(7):774-82. PubMed ID: 12135676
[TBL] [Abstract][Full Text] [Related]
8. Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria.
Kawagoe K; Kitamura D; Okabe M; Taniuchi I; Ikawa M; Watanabe T; Kinoshita T; Takeda J
Blood; 1996 May; 87(9):3600-6. PubMed ID: 8611683
[TBL] [Abstract][Full Text] [Related]
9. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
Maciejewski JP; Sloand EM; Sato T; Anderson S; Young NS
Blood; 1997 Feb; 89(4):1173-81. PubMed ID: 9028939
[TBL] [Abstract][Full Text] [Related]
10. CD34+ cells from paroxysmal nocturnal hemoglobinuria (PNH) patients are deficient in surface expression of cellular prion protein (PrPc).
Risitano AM; Holada K; Chen G; Simak J; Vostal JG; Young NS; Maciejewski JP
Exp Hematol; 2003 Jan; 31(1):65-72. PubMed ID: 12543108
[TBL] [Abstract][Full Text] [Related]
11. Increased resistance of PIG-A- bone marrow progenitors to tumor necrosis factor a and interferon gamma: possible implications for the in vivo dominance of paroxysmal nocturnal hemoglobinuria clones.
Barcellini W; Fermo E; Guia Imperiali F; Zaninoni A; Bianchi P; Boschetti C; Zanella A
Haematologica; 2004 Jun; 89(6):651-6. PubMed ID: 15194531
[TBL] [Abstract][Full Text] [Related]
12. Paroxysmal nocturnal hemoglobinuria: stem cells and clonality.
Brodsky RA
Hematology Am Soc Hematol Educ Program; 2008; ():111-5. PubMed ID: 19074067
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of paroxysmal nocturnal hemoglobinuria.
Parker CJ
Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
[TBL] [Abstract][Full Text] [Related]
14. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of paroxysmal nocturnal hemoglobinuria clonal dominance: possible roles of different apoptosis and CD8+ lymphocytes in the selection of paroxysmal nocturnal hemoglobinuria clones.
Kunyaboon R; Wanachiwanawin W; U-Pratya Y; Thedsawad A; Taka O
Hematol Oncol Stem Cell Ther; 2012; 5(3):138-45. PubMed ID: 23095789
[TBL] [Abstract][Full Text] [Related]
16. The Role of T Lymphocytes in the Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria.
Li C; Dong X; Wang H; Shao Z
Front Immunol; 2021; 12():777649. PubMed ID: 35003092
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of paroxysmal nocturnal hemoglobinuria.
Inoue N; Murakami Y; Kinoshita T
Int J Hematol; 2003 Feb; 77(2):107-12. PubMed ID: 12627844
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.
Maciejewski JP; Young NS; Yu M; Anderson SM; Sloand EM
Thromb Res; 1996 Sep; 83(6):433-47. PubMed ID: 8885138
[TBL] [Abstract][Full Text] [Related]
19. Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP.
Hanaoka N; Kawaguchi T; Horikawa K; Nagakura S; Mitsuya H; Nakakuma H
Blood; 2006 Feb; 107(3):1184-91. PubMed ID: 16195329
[TBL] [Abstract][Full Text] [Related]
20. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.
van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H
Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
